[MNPR] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[MNPR] Monopar Therapeutics Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 13.11%
YoY- 2.36%
Quarter Report
MNPR's Result
MNPR's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,200 -2,435 -2,896 -2,400 -2,763 -2,457 -2,681 -12.38%
Tax 128,087 -90 -14 -2,407 -1 -1 -1 -
NP -2,200 -2,344 -2,883 -2,400 -2,762 -2,456 -2,681 -12.38%
Tax Rate - - - - - - - -
Total Cost 2,200 2,344 2,883 2,400 2,762 2,456 2,681 -12.38%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.16 -0.18 -0.22 -0.19 -0.22 -0.19 -0.21 -16.62%
EPS Diluted -0.16 -0.18 -0.22 -0.19 -0.22 -0.19 -0.21 -16.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.